WFC Research Update — April 22, 2026
Updated Thesis
Wells Fargo & Company is a diversified financial services firm operating primarily in consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. The company benefits from a seasoned CEO with extensive industry experience and has made significant progress in regulatory compliance and operational efficiency, including lifting its asset cap in 2025. Despite a fair valuation regime with a current price of $81.52 and a fair value estimate of $106.49 implying 30.6% upside, the stock trades at a trailing and forward P/E of 11.92, reflecting moderate earnings growth of 8.1% and revenue growth of 7.3% in the most recent quarter.
The investment grade as of this refresh is B — solid business quality. Medium-tier business, fair-tier valuation with 30.6% upside to $106.49 fair value
Key Metrics at a Glance
- Revenue growth: +7.3% year over year
- Net margin: 17.3%
- Forward P/E: 11.9x
- Fair value upside: +30.6% to our estimate of $106
Current price: $81.52
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Wells Fargo & Company remains in our covered universe with a solid-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full WFC research →](/stocks/WFC)